Wikidata

(Q44141410)

English

Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study

scientific article published in September 2002

In more languages

Statements

title
Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12237621
retrieved
30 November 2017
author name string
Steven R Goldstein
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12237621
retrieved
30 November 2017
Nayan Nanavati
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12237621
retrieved
30 November 2017
publication date
1 September 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
12237621
retrieved
30 November 2017
page(s)
521-527
1 reference
stated in
Europe PubMed Central
PubMed ID
12237621
retrieved
30 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44141410&oldid=2107056878"